Number of events in randomized controlled trials comparing combination therapy with angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitor therapy versus ACE inhibitor alone in patients with congestive heart failure.

THE COMPARISON OF 1ST DOSE HYPOTENSION WITH ACE (CAPTOPRIL) IN NORMOVOLEMIC AND HYPOVOLEMIC PATIENTS WITH CARDIAC FAILURE

Dr Hina Akram, Dr Muqaddas Mujeeb, Dr Samreen Asif

July 2019

Angiotensin-converting enzyme inhibitors are preferred drugs in congestive heart failure. The incide...

Underutilization of Angiotensin Converting Enzyme Inhibitors among Heart Failure Patients

Lean, Q.Y.
Shamsuddin, N.
Wan Ahmad, W.A.

January 2008

There are well established guidelines regarding the use of Angiotensin converting enzyme inhibitors ...

Adverse effects in randomized controlled trials comparing angiotensin receptor antagonists and ACE inhibitors versus ACE inhibitors alone in patients with heart failure.

Andrea Kuenzli (365854)
Heiner C. Bucher (134728)
Inder Anand (365855)
Gregory Arutiunov (365856)
Leo C. Kum (365857)
Robert McKelvie (365858)
Rizwan Afzal (365859)
Michel White (303419)
Alain J. Nordmann (365860)

February 2013

Adverse effects in randomized controlled trials comparing angiotensin receptor antagonists and AC...

Baseline characteristics of patients enrolled in randomized controlled trials comparing combination therapy with angiotensin II receptor antagonists and ACE inhibitor therapy versus ACE inhibitor therapy alone in patients with congestive heart failure.

Andrea Kuenzli (365854)
Heiner C. Bucher (134728)
Inder Anand (365855)
Gregory Arutiunov (365856)
Leo C. Kum (365857)
Robert McKelvie (365858)
Rizwan Afzal (365859)
Michel White (303419)
Alain J. Nordmann (365860)

February 2013

ACE-I angiotensin-converting enzyme inhibitor, EF ejection fraction, MI myocardial infarction, n ...

ACE INHIBITION VERSUS ANGIOTENSIN-II ANTAGONISM IN HEART FAILURE

Mahesh Chandra Md

October 2016

Heart failure is becoming increasingly frequent. Once diagnosed, 5-year survival is less than 50 % a...

Trial characteristics of randomized controlled trials comparing combination therapy with angiotensin II receptor antagonists and ACE inhibitor therapy versus ACE inhibitor therapy alone in patients with congestive heart failure.

Andrea Kuenzli (365854)
Heiner C. Bucher (134728)
Inder Anand (365855)
Gregory Arutiunov (365856)
Leo C. Kum (365857)
Robert McKelvie (365858)
Rizwan Afzal (365859)
Michel White (303419)
Alain J. Nordmann (365860)

February 2013

Abbreviations: ARB angiotensin II receptor antagonist, ACE angiotensin-converting enzyme, BP bloo...

Mortality and cardiovascular outcomes in randomized controlled trials comparing angiotensin receptor antagonists and ACE inhibitors versus ACE inhibitors alone in patients with heart failure.

Andrea Kuenzli (365854)
Heiner C. Bucher (134728)
Inder Anand (365855)
Gregory Arutiunov (365856)
Leo C. Kum (365857)
Robert McKelvie (365858)
Rizwan Afzal (365859)
Michel White (303419)
Alain J. Nordmann (365860)

February 2013

Mortality and cardiovascular outcomes in randomized controlled trials comparing angiotensin recep...

Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.

Andrea Kuenzli
Heiner C Bucher
Inder Anand
Gregory Arutiunov
Leo C Kum
Robert McKelvie
Rizwan Afzal
Michel White
Alain J Nordmann

BACKGROUND: There is insufficient evidence whether the benefit of adding angiotensin II receptor blo...

Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism

Brunner-La Rocca, Hans Peter
Vaddadi, Gautam
Esler, Murray D.

April 1999

AbstractOne possible intervention to interrupt the deleterious effects of the renin-angiotensin syst...

Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure

Kuenzli Andrea
Bucher Heiner C.
Anand Inder
Arutiunov Gregory
Kum Leo C.
McKelvie Robert
Afzal Rizwan
White Michel
Nordmann Alain J.

April 2010

There is insufficient evidence whether the benefit of adding angiotensin II receptor blockers (ARBs)...

Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction

Savarese, Gianluigi
Edner, Magnus
Dahlström, Ulf
Perrone Filardi, Pasquale
Hage, Camilla
Cosentino, Francesco
Lund, Lars H.

January 2015

Background: Angiotensin converting enzyme inhibitors (ACE-Is) and angiotensin receptor blockers (ARB...

A hard look at angiotensin receptor blockers in heart failure

Gring, Christian N.
Francis, Gary S.

November 2004

Multiple trials over the past several years have examined indications for angiotensin receptor block...

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?

S. Y. Martsevich
S. N. Tolpygina

December 2015

Data of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute...

The intersection between acute coronary syndrome and heart failure

M. A. Pfeffer

January 2015

There is a tremendous spectrum of disease severity within the diagnosis of myocardial infarction. Th...

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.

Latini, R
Tognoni, G
Maggioni, A
Baigent, C
Braunwald, E
Chen, Z
Collins, R
Flather, M
Franzosi, MG
Kjekshus, J
Køber, L
Liu, L
Peto, R
Pfeffer, M
Pizzetti, F
Santoro, E
Sleight, P
Swedberg, K
Tavazzi, L
Wang, W
Yusuf, S

January 2000

OBJECTIVES: We sought to determine whether the clinical effects of early angiotensin-converting enzy...

THE COMPARISON OF 1ST DOSE HYPOTENSION WITH ACE (CAPTOPRIL) IN NORMOVOLEMIC AND HYPOVOLEMIC PATIENTS WITH CARDIAC FAILURE

Dr Hina Akram, Dr Muqaddas Mujeeb, Dr Samreen Asif

July 2019

Angiotensin-converting enzyme inhibitors are preferred drugs in congestive heart failure. The incide...

Underutilization of Angiotensin Converting Enzyme Inhibitors among Heart Failure Patients

Lean, Q.Y.
Shamsuddin, N.
Wan Ahmad, W.A.

January 2008

There are well established guidelines regarding the use of Angiotensin converting enzyme inhibitors ...

Adverse effects in randomized controlled trials comparing angiotensin receptor antagonists and ACE inhibitors versus ACE inhibitors alone in patients with heart failure.

Andrea Kuenzli (365854)
Heiner C. Bucher (134728)
Inder Anand (365855)
Gregory Arutiunov (365856)
Leo C. Kum (365857)
Robert McKelvie (365858)
Rizwan Afzal (365859)
Michel White (303419)
Alain J. Nordmann (365860)

February 2013

Adverse effects in randomized controlled trials comparing angiotensin receptor antagonists and AC...

Baseline characteristics of patients enrolled in randomized controlled trials comparing combination therapy with angiotensin II receptor antagonists and ACE inhibitor therapy versus ACE inhibitor therapy alone in patients with congestive heart failure.

Andrea Kuenzli (365854)
Heiner C. Bucher (134728)
Inder Anand (365855)
Gregory Arutiunov (365856)
Leo C. Kum (365857)
Robert McKelvie (365858)
Rizwan Afzal (365859)
Michel White (303419)
Alain J. Nordmann (365860)

February 2013

ACE-I angiotensin-converting enzyme inhibitor, EF ejection fraction, MI myocardial infarction, n ...

ACE INHIBITION VERSUS ANGIOTENSIN-II ANTAGONISM IN HEART FAILURE

Mahesh Chandra Md

October 2016

Heart failure is becoming increasingly frequent. Once diagnosed, 5-year survival is less than 50 % a...

Trial characteristics of randomized controlled trials comparing combination therapy with angiotensin II receptor antagonists and ACE inhibitor therapy versus ACE inhibitor therapy alone in patients with congestive heart failure.

Andrea Kuenzli (365854)
Heiner C. Bucher (134728)
Inder Anand (365855)
Gregory Arutiunov (365856)
Leo C. Kum (365857)
Robert McKelvie (365858)
Rizwan Afzal (365859)
Michel White (303419)
Alain J. Nordmann (365860)

February 2013

Abbreviations: ARB angiotensin II receptor antagonist, ACE angiotensin-converting enzyme, BP bloo...

Mortality and cardiovascular outcomes in randomized controlled trials comparing angiotensin receptor antagonists and ACE inhibitors versus ACE inhibitors alone in patients with heart failure.

Andrea Kuenzli (365854)
Heiner C. Bucher (134728)
Inder Anand (365855)
Gregory Arutiunov (365856)
Leo C. Kum (365857)
Robert McKelvie (365858)
Rizwan Afzal (365859)
Michel White (303419)
Alain J. Nordmann (365860)

February 2013

Mortality and cardiovascular outcomes in randomized controlled trials comparing angiotensin recep...

Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.

Andrea Kuenzli
Heiner C Bucher
Inder Anand
Gregory Arutiunov
Leo C Kum
Robert McKelvie
Rizwan Afzal
Michel White
Alain J Nordmann

BACKGROUND: There is insufficient evidence whether the benefit of adding angiotensin II receptor blo...

Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism

Brunner-La Rocca, Hans Peter
Vaddadi, Gautam
Esler, Murray D.

April 1999

AbstractOne possible intervention to interrupt the deleterious effects of the renin-angiotensin syst...

Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure

Kuenzli Andrea
Bucher Heiner C.
Anand Inder
Arutiunov Gregory
Kum Leo C.
McKelvie Robert
Afzal Rizwan
White Michel
Nordmann Alain J.

April 2010

There is insufficient evidence whether the benefit of adding angiotensin II receptor blockers (ARBs)...

Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction

Savarese, Gianluigi
Edner, Magnus
Dahlström, Ulf
Perrone Filardi, Pasquale
Hage, Camilla
Cosentino, Francesco
Lund, Lars H.

January 2015

Background: Angiotensin converting enzyme inhibitors (ACE-Is) and angiotensin receptor blockers (ARB...

A hard look at angiotensin receptor blockers in heart failure

Gring, Christian N.
Francis, Gary S.

November 2004

Multiple trials over the past several years have examined indications for angiotensin receptor block...

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?

S. Y. Martsevich
S. N. Tolpygina

December 2015

Data of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute...

The intersection between acute coronary syndrome and heart failure

M. A. Pfeffer

January 2015

There is a tremendous spectrum of disease severity within the diagnosis of myocardial infarction. Th...

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.

Latini, R
Tognoni, G
Maggioni, A
Baigent, C
Braunwald, E
Chen, Z
Collins, R
Flather, M
Franzosi, MG
Kjekshus, J
Køber, L
Liu, L
Peto, R
Pfeffer, M
Pizzetti, F
Santoro, E
Sleight, P
Swedberg, K
Tavazzi, L
Wang, W
Yusuf, S

January 2000

OBJECTIVES: We sought to determine whether the clinical effects of early angiotensin-converting enzy...

THE COMPARISON OF 1ST DOSE HYPOTENSION WITH ACE (CAPTOPRIL) IN NORMOVOLEMIC AND HYPOVOLEMIC PATIENTS WITH CARDIAC FAILURE

Dr Hina Akram, Dr Muqaddas Mujeeb, Dr Samreen Asif

July 2019

Angiotensin-converting enzyme inhibitors are preferred drugs in congestive heart failure. The incide...

Underutilization of Angiotensin Converting Enzyme Inhibitors among Heart Failure Patients

Lean, Q.Y.
Shamsuddin, N.
Wan Ahmad, W.A.

January 2008

There are well established guidelines regarding the use of Angiotensin converting enzyme inhibitors ...

Adverse effects in randomized controlled trials comparing angiotensin receptor antagonists and ACE inhibitors versus ACE inhibitors alone in patients with heart failure.

Andrea Kuenzli (365854)
Heiner C. Bucher (134728)
Inder Anand (365855)
Gregory Arutiunov (365856)
Leo C. Kum (365857)
Robert McKelvie (365858)
Rizwan Afzal (365859)
Michel White (303419)
Alain J. Nordmann (365860)

February 2013

Adverse effects in randomized controlled trials comparing angiotensin receptor antagonists and AC...

Number of events in randomized controlled trials comparing combination therapy with angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitor therapy versus ACE inhibitor alone in patients with congestive heart failure.

Abstract

Extracted data

Number of events in randomized controlled trials comparing combination therapy with angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitor therapy versus ACE inhibitor alone in patients with congestive heart failure.

Abstract

Extracted data

Related items

Related items